Spinogenix
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A neuroscience biotech developing small molecules to regenerate synapses for neurodegenerative diseases.
NeuroscienceNeurodegenerative Diseases
Technology Platform
A platform for discovering small molecules that promote synaptogenesis (the formation of new synapses) to repair neural circuits in neurodegenerative diseases.
Opportunities
Addressing a huge unmet need with a potentially transformative mechanism that could apply to multiple neurodegenerative conditions.
Risk Factors
Extremely high clinical development risk due to the complexity of the brain and the historical high failure rate in neurodegenerative drug trials.
Competitive Landscape
A unique player in neurodegeneration, facing competition from larger biopharma but with a differentiated focus on synaptic repair versus protein clearance.